Raloxifene hydrochloride 60 MG Oral Tablet — RxCUI 1490065
RxNorm drug concept · Semantic clinical drug
RxCUI 1490065
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
59 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1490065
Official nameRaloxifene hydrochloride 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asraloxifene HCl 60 MG Oral Tablet
FDA products mapped23
Package NDCs mapped59
Reported Medicaid activity (SDUD)20,163 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Raloxifene: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats and prevents osteoporosis in women after menopause. It also lowers the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk. It is not...
- Take it by mouth once a day, any time of day, with or without food. Pick a time you will remember. Follow your prescriber's directions, and ask whether you need calcium or vitamin...
- The most common are hot flashes, leg cramps, swelling in the legs or feet, flu-like symptoms, joint pain and sweating. Most are mild. Call your doctor if they bother you.
- Sudden leg pain or swelling, sudden shortness of breath, chest pain, sudden vision changes, or stroke signs like weakness or trouble speaking need emergency care. Raloxifene raises...
🕸️ Concept Web — How Raloxifene hydrochloride 60 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Raloxifene hydrochloride 60 MG Oral Tablet
RxCUI 1490065 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Raloxifene
72143IN -
Raloxifene hydrochloride
166551PIN
-
Raloxifene
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Evista
217010BN
-
Evista
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Raloxifene Oral Tablet
373747SCDF -
Raloxifene hydrochloride Oral Tablet
2646882SCDFP -
Raloxifene Oral Product
1164805SCDG -
Raloxifene Pill
1164806SCDG -
Raloxifene hydrochloride Oral Product
2663197SCDGP -
Raloxifene hydrochloride Pill
2659513SCDGP -
Raloxifene Oral Tablet [Evista]
368299SBDF -
Raloxifene hydrochloride Oral Tablet [Evista]
2656333SBDFP - +5 more in this family
-
Raloxifene Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Raloxifene hydrochloride 60 MG
1490064SCDC -
Raloxifene hydrochloride 60 MG Oral Tablet [Evista]
1490067SBD -
Raloxifene hydrochloride 60 MG [Evista]
1490066SBDC
-
Raloxifene hydrochloride 60 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Raloxifene hydrochloride 60 MG
SCDC · 1490064 -
Raloxifene Oral Tablet
SCDF · 373747 -
Raloxifene hydrochloride Oral Tablet
SCDFP · 2646882 -
Raloxifene Oral Product
SCDG · 1164805 -
Raloxifene Pill
SCDG · 1164806 -
Raloxifene hydrochloride Oral Product
SCDGP · 2663197 -
Raloxifene hydrochloride Pill
SCDGP · 2659513
Brand-Name Concepts
-
Raloxifene hydrochloride 60 MG Oral Tablet [Evista]
SBD · 1490067 -
Raloxifene hydrochloride 60 MG [Evista]
SBDC · 1490066 -
Raloxifene Oral Tablet [Evista]
SBDF · 368299 -
Raloxifene hydrochloride Oral Tablet [Evista]
SBDFP · 2656333 -
Evista Oral Product
SBDG · 1171809 -
Evista Pill
SBDG · 1171810 -
Evista
BN · 217010
📦 FDA Products & Package NDCs
23 products · 59 package NDCs
59 package NDCs map to RxCUI 1490065 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-4184-30 | 30 TABLET in 1 BOTTLE (0002-4184-30) | Evista | Eli Lilly and Company | 2016-12-16 |
| 00093-7290-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-7290-01) | Raloxifene Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2014-03-28 |
| 00093-7290-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-7290-56) | Raloxifene Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2014-03-28 |
| 00904-6902-04 | 30 BLISTER PACK in 1 CARTON (0904-6902-04) / 1 TABLET, FILM... | Raloxifene hydrochloride | Major Pharmaceuticals | 2016-10-12 |
| 16714-0213-01 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-213-01) | Raloxifene Hydrochloride | NorthStar Rx LLC | 2015-08-28 |
| 16714-0213-02 | 100 TABLET, FILM COATED in 1 BOTTLE (16714-213-02) | Raloxifene Hydrochloride | NorthStar Rx LLC | 2015-08-28 |
| 16714-0213-03 | 1000 TABLET, FILM COATED in 1 BOTTLE (16714-213-03) | Raloxifene Hydrochloride | NorthStar Rx LLC | 2015-08-28 |
| 43598-0505-01 | 100 TABLET, FILM COATED in 1 BOTTLE (43598-505-01) | Raloxifene hydrochloride | Dr.Reddys Laboratories Inc | 2016-10-12 |
| 43598-0505-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (43598-505-10) | Raloxifene hydrochloride | Dr.Reddys Laboratories Inc | 2016-10-12 |
| 43598-0505-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-505-30) | Raloxifene hydrochloride | Dr.Reddys Laboratories Inc | 2016-10-12 |
| 50090-6177-01 | 90 TABLET, COATED in 1 BOTTLE (50090-6177-1) | Raloxifene hydrochloride | A-S Medication Solutions | 2022-10-18 |
| 50090-7073-01 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7073-1) | Raloxifene Hydrochloride | A-S Medication Solutions | 2024-01-23 |
| 50228-0306-20 | 2000 TABLET, FILM COATED in 1 BOTTLE (50228-306-20) | Raloxifene hydrochloride | ScieGen Pharmaceuticals Inc | 2016-10-12 |
| 50228-0306-30 | 30 TABLET, FILM COATED in 1 BOTTLE (50228-306-30) | Raloxifene hydrochloride | ScieGen Pharmaceuticals Inc | 2016-10-12 |
| 50268-0694-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-694-15) / 1 TABL... | Raloxifene Hydrochloride | AvPAK | 2018-06-27 |
| 60687-0266-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-266-21) / 1 TABL... | Raloxifene Hydrochloride | American Health Packaging | 2016-11-09 |
| 65162-0057-03 | 30 TABLET, FILM COATED in 1 BOTTLE (65162-057-03) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65162-0057-09 | 90 TABLET, FILM COATED in 1 BOTTLE (65162-057-09) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65162-0057-10 | 100 TABLET, FILM COATED in 1 BOTTLE (65162-057-10) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65162-0057-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (65162-057-11) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65162-0057-33 | 2000 TABLET, FILM COATED in 1 BOTTLE (65162-057-33) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65162-0057-50 | 500 TABLET, FILM COATED in 1 BOTTLE (65162-057-50) | Raloxifene Hydrochloride | Amneal Pharmaceuticals LLC | 2016-01-20 |
| 65862-0709-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-709-01) | Raloxifene Hydrochloride | Aurobindo Pharma Limited | 2015-08-28 |
| 65862-0709-03 | 3 BLISTER PACK in 1 CARTON (65862-709-03) / 10 TABLET, FILM... | Raloxifene Hydrochloride | Aurobindo Pharma Limited | 2015-08-28 |
| 65862-0709-22 | 2000 TABLET, FILM COATED in 1 BOTTLE (65862-709-22) | Raloxifene Hydrochloride | Aurobindo Pharma Limited | 2015-08-28 |
| 65862-0709-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-709-30) | Raloxifene Hydrochloride | Aurobindo Pharma Limited | 2015-08-28 |
| 65862-0709-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-709-99) | Raloxifene Hydrochloride | Aurobindo Pharma Limited | 2015-08-28 |
| 68462-0393-01 | 100 TABLET, FILM COATED in 1 BOTTLE (68462-393-01) | raloxifene hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2016-03-22 |
| 68462-0393-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68462-393-10) | raloxifene hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2016-03-22 |
| 68462-0393-23 | 2000 TABLET, FILM COATED in 1 BOTTLE (68462-393-23) | raloxifene hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2016-03-22 |
| 68462-0393-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68462-393-30) | raloxifene hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2016-03-22 |
| 68462-0393-90 | 90 TABLET, FILM COATED in 1 BOTTLE (68462-393-90) | raloxifene hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2016-03-22 |
| 69097-0825-02 | 30 TABLET in 1 BOTTLE (69097-825-02) | Raloxifene Hydrochloride | Cipla USA Inc. | 2016-06-29 |
| 69097-0825-07 | 100 TABLET in 1 BOTTLE (69097-825-07) | Raloxifene Hydrochloride | Cipla USA Inc. | 2016-06-29 |
| 69097-0825-15 | 1000 TABLET in 1 BOTTLE (69097-825-15) | Raloxifene Hydrochloride | Cipla USA Inc. | 2016-06-29 |
| 71209-0082-01 | 30 TABLET, COATED in 1 BOTTLE (71209-082-01) | Raloxifene hydrochloride | Cadila Pharmaceuticals Limited | 2017-12-30 |
| 71209-0082-05 | 100 TABLET, COATED in 1 BOTTLE (71209-082-05) | Raloxifene hydrochloride | Cadila Pharmaceuticals Limited | 2017-12-30 |
| 71209-0082-11 | 1000 TABLET, COATED in 1 BOTTLE (71209-082-11) | Raloxifene hydrochloride | Cadila Pharmaceuticals Limited | 2021-12-13 |
| 71209-0082-13 | 2000 TABLET, COATED in 1 BOTTLE (71209-082-13) | Raloxifene hydrochloride | Cadila Pharmaceuticals Limited | 2017-12-30 |
| 71335-1460-01 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-1460-1) | Raloxifene hydrochloride | Bryant Ranch Prepack | 2020-01-03 |
| 71335-1460-02 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-1460-2) | Raloxifene hydrochloride | Bryant Ranch Prepack | 2021-12-28 |
| 71335-1715-01 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-1715-1) | Raloxifene Hydrochloride | Bryant Ranch Prepack | 2020-10-02 |
| 71335-1715-02 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-1715-2) | Raloxifene Hydrochloride | Bryant Ranch Prepack | 2021-12-29 |
| 71335-2059-01 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-2059-1) | Raloxifene Hydrochloride | Bryant Ranch Prepack | 2022-03-03 |
| 71335-2059-02 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2059-2) | Raloxifene Hydrochloride | Bryant Ranch Prepack | 2024-02-27 |
| 71610-0053-60 | 90 TABLET, FILM COATED in 1 BOTTLE (71610-053-60) | Raloxifene hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2018-04-26 |
| 71610-0524-60 | 90 TABLET in 1 BOTTLE (71610-524-60) | Raloxifene Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2021-02-03 |
| 72162-2418-00 | 1000 TABLET, COATED in 1 BOTTLE (72162-2418-0) | Raloxifene hydrochloride | Bryant Ranch Prepack | 2024-10-31 |
| 72162-2418-01 | 100 TABLET, COATED in 1 BOTTLE (72162-2418-1) | Raloxifene hydrochloride | Bryant Ranch Prepack | 2024-10-31 |
| 72162-2418-03 | 30 TABLET, COATED in 1 BOTTLE (72162-2418-3) | Raloxifene hydrochloride | Bryant Ranch Prepack | 2024-10-31 |
Observed labelers:
Bryant Ranch Prepack (9) ·
Amneal Pharmaceuticals LLC (6) ·
Aurobindo Pharma Limited (5) ·
Exelan Pharmaceuticals, Inc. (5) ·
Glenmark Pharmaceuticals Inc., USA (5) ·
Cadila Pharmaceuticals Limited (4)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.